Sponsored by: Fujifilm

Montreal Skyline

May 10, 2019
Latest in MRI
An IMRIS ceiling-mounted diagnostic and intraoperative MRI system.
IMRIS’ new MRI system secures U.S. FDA clearance
August 13, 2025
Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite
Sponsored
Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite
January 1, 2025
Fda Sign Dc 400
Polarean submits trial protocol to FDA for MRI contrast agent
August 12, 2025
Mri Scanner Kid
Watching a movie during MR imaging reduces kids' need for sedation
August 6, 2025
Related Stories
2018 11 19 19 27 1139 Mri Brain 400
MRI
Deep learning finds, segments brain metastases on MRI
2019 05 03 19 57 9383 Honolulu 20190503193859
MRI
ARRS: MRI protocols don't affect hip implant temperature
2018 12 21 22 34 2777 United Imaging Rsna 2018 400
Molecular Imaging
United Imaging gets FDA nod for PET/MRI scanner
Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite
Sponsor Content
Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite
More in MRI
IMRIS’ new MRI system secures U.S. FDA clearance
By AuntMinnie.com staff writers
The system provides a path for IMRIS Operating Suites to upgrade MRI scanners.
August 13, 2025
An IMRIS ceiling-mounted diagnostic and intraoperative MRI system.
How multiparametric MRI can improve prostate cancer detection
By Kate Madden Yee
The study results could help further clarify the modality's benefits for this indication.
August 12, 2025
Prostate Cancer 2
Polarean submits trial protocol to FDA for MRI contrast agent
By AuntMinnie.com staff writers
Polarean has submitted a clinical trial protocol to the U.S. FDA for an expanded indication for its lung MRI Xenoview contrast agent.
August 12, 2025
Fda Sign Dc 400
Watching a movie during MR imaging reduces kids' need for sedation
By Kate Madden Yee
The findings are good news for pediatric patients, who often struggle to remain still during an MRI exam.
August 6, 2025
Mri Scanner Kid
Is imaging being used to its full potential to diagnose dementia?
By Kate Madden Yee
As disease-modifying therapies for various types of dementia become more available, MR and CT imaging predominate for diagnosis.
August 6, 2025
Brain Puzzle Dementia
MRI shows promise profiling hepatocellular carcinoma tumors
By Will Morton
A study suggests that imaging-based screening with targeted pathological workup could help refine treatment strategies.
August 5, 2025
2025 08 05 Mri Molecular Profiles Thumbnail
MRI-based DL model improves ovarian lesion classification
By Amerigo Allegretto
A deep-learning (DL) model accurately differentiated malignant from benign ovarian lesions on MRI scans and reduced segmentation time.
August 5, 2025
Ovarian Cancer2 400
Hyperfine enrolls 100th patient in neurology study
By AuntMinnie.com staff writers
The company reached this milestone 16 weeks after the study began, it said.
August 4, 2025
Hyperfine
fMRI confirms yet again that exercise really does improve mood
By Kate Madden Yee
The findings offer a "more nuanced neurobiological model for the therapeutic effects of exercise," the researchers noted.
July 31, 2025
Runner Woman Adobe Izf
Hyperfine highlights first patients enrolled in PRIME study
By AuntMinnie.com staff writers
Hyperfine has enrolled the first patients in a study that will evaluate the effectiveness of the Swoop portable MRI system.
July 31, 2025
Emergency Entrance 400
MRI-based model predicts treatment response in breast cancer patients
By Amerigo Allegretto
An MRI-based model performed well in predicting pathologic complete response in women with triple-negative breast cancer.
July 30, 2025
MR image from a 55-year-old patient with triple-negative breast cancer from training set. (A, above) Axial postcontrast T1-weighted image from baseline MRI exam shows unifocal enhancing mass (unifocality: positive). (B, below) Axial postcontrast T1-weighted image from MRI examination per-formed after one cycle of neoadjuvant chemoimmunotherapy shows >37% reduction in lesion size (early tumor shrinkage: positive) and development of non-enhancing region within lesion (percentage enhancement reduction: positive).
Data transparency is lacking for FDA-cleared Alzheimer's AI technology
By Liz Carey
Lack of transparency raises concerns about algorithmic bias impacting care planning for patients with Alzheimer's disease.
July 30, 2025
Amyloid Plaque Alzheimer
Page 1 of 624
Next Page